Prevalence and Predictors of Vascular Cognitive Impairment in Patients With CADASIL

Amy A Jolly1, Stefania Nannoni2, Hayley Edwards2

  • 1From the Stroke Research Group, Department of Clinical Neurosciences (A.A.J., S.N., H.E., H.S.M.), University of Cambridge, Cambridge Biomedical Campus, United Kingdom; and Department of Psychology (R.G.M.), King's College Institute of Psychiatry, Psychology and Neurosciences, Institute of Psychiatry, London, United Kingdom. aj602@medschl.cam.ac.uk.

Neurology
|May 23, 2022
PubMed

Insights

Vascular cognitive impairment (VCI) affects nearly half of CADASIL patients. Stroke history and MRI-detected lacunes are key predictors of VCI in this genetic stroke disorder.

Area of Science:

  • Neurology
  • Genetics
  • Neuroimaging

Background:

  • Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL) is the most common monogenic cause of stroke and early-onset dementia.
  • Understanding the prevalence and predictors of vascular cognitive impairment (VCI) in CADASIL is crucial for patient management.

Purpose of the Study:

  • To determine the prevalence of VCI in patients with genetically confirmed CADASIL.
  • To identify clinical, genetic, and MRI factors associated with VCI risk in CADASIL.

Main Methods:

  • Cognitive function was assessed in 176 CADASIL patients and 265 controls using the Brief Memory and Executive Test (BMET) and Montreal Cognitive Assessment (MoCA).
  • VCI was defined using validated cutoffs.
  • Associations between VCI and clinical factors, mutation location, and MRI markers of small vessel disease were analyzed.

Main Results:

  • VCI prevalence was significantly higher in CADASIL patients (39.8% on BMET, 47.7% on MoCA) compared to controls (10.2% on BMET, 19.6% on MoCA).
  • CADASIL patients exhibited poorer performance across all cognitive domains.
  • A history of stroke independently predicted VCI (BMET: OR 2.12, MoCA: OR 2.55).
  • Lacune count on MRI was the sole independent MRI predictor of VCI (BMET: OR 1.63).
  • No association was found between VCI and mutation site.

Conclusions:

  • VCI affects nearly half of CADASIL patients, even at a mean age of 50.
  • Stroke history and the number of lacunes on MRI are significant independent predictors of VCI in CADASIL.
Abstract

Related Concept Videos

Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
74
Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT01:25

Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT

Calcium-Scoring CT ScanA calcium-scoring CT scan, also known as coronary artery calcium (CAC) scan, detects calcium deposits in the coronary arteries. This test assesses the risk of coronary artery disease (CAD), which can lead to cardiovascular events such as angina, heart failure, and sudden cardiac arrest.A calcium-scoring CT scan is generally recommended for individuals at intermediate risk of CAD without symptoms. It includes:Men aged 40-75 and women aged 50-75: Especially those with a...
137
Coronary Artery Disease III: Clinical Manifestations01:30

Coronary Artery Disease III: Clinical Manifestations

Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
42
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests01:27

Atherosclerosis II: Clinical Manifestations and Diagnostic Tests

Atherosclerosis is a progressive disorder that leads to the thickening and narrowing of arterial walls due to plaque buildup. This condition can cause various symptoms depending on the arteries affected:Coronary Artery Disease (CAD): This condition affects the coronary arteries and may lead to chest pain (angina), shortness of breath (dyspnea), heart attacks, and other heart disease symptoms.Cerebrovascular Disease: This affects blood flow to the brain, causing transient ischemic attacks (TIAs)...
54
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
44
Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation01:21

Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation

Clinical manifestationsPeripheral Arterial Disease (PAD) manifests through a range of symptoms, from the characteristic intermittent claudication to atypical presentations and severe complications in advanced stages. Intermittent claudication, a hallmark symptom of PAD, presents as exercise-induced muscle pain that typically resolves within minutes of rest. This pain is reproducible and stems from inadequate blood flow, leading to the accumulation of lactic acid produced during anaerobic...
42